62 / 140
184
REFERENCIAS BIBLIOGRÁFICAS
1. Booth GL, Kapral MK, Fung K, et al. Relation between age and
cardiovascular disease in men and women with diabetes compared
with non-diabetic people: a population-based retrospective cohort
study. Lancet. 2006;368: 29-36.
2. Haffner S M, Lehto S, Rönenemaa T et al.: Mortality from coronary
herat disease in subjects with type 2 diabetes and in non diabetic
subjects with and without prior myocardial infarction. N Engl J Med
1998; 339: 229 – 234
3. Evan JMM, Wang J, Morris AD. Comparison of cardiovascular risk
between patients with type 2 diabetes and those who had had
a myocardial infarction: cross sectional and cohort studies.BMJ.
2002;324: 939-942
4. Malmberg K,Yusuf S, Gerstein HC, et al. Impact of diabeteson
long-term prognosis in patients with unstable angina and non-Q-
wave myocardial infarction: results of the OASIS (Organization to
Assess Strategies for Ischemic Syndromes) Registry. Circulation.
2000;102:1014-1019.
5. Ali MK,Bullard KM,Saddine JB,Cowie CC, Imperatore G, Greeg EW.
Achievementof goals in U.S. dibetes care1999-2010. N Engl J Med
2013; 368:1613-1624
6. Teno S, Uto Y, Nagashima H et al.: Association of postprandial
hypertriglyceridemia and carotid intima –media thickness in patients
with type 2 diabetes Diabetes Care 2000; 23:1401- 1406
7. MargolisJR, Kannel WS, Feinleib M et al.: Clinical features of
unrecognized myocardial infarction-silent and asymptomatic.
Eighteen year follow-up: the Framingham study .Am J Cardiol
1973;32:1-7
8. Lee DP, Fearon WF, Froelicher VF. Clinical utility of the exercise ECG
in patients with diabetes and chest pain. Chest 2001; 119:1576-
1581.
9. Muhlstein JB, lappé DL, Lima JA et al. Effect of screening for CAD using
CT angiography in high risk patients with Diabetes. JAMA 2014; 312:
2234-2243
10.Turner RC, Millns H, Neil HA, et al. Risk factors for coronary artery
disease in non-insulin dependent diabetes mellitus: United Kingdom
Prospective Diabetes Study (UKPDS: 23).BMJ. 1998;316:823-828.
11.Gaede P, Vedel P, Larsen N et al.: Multifactorial Intervention and
Cardiovascular Disease in Patients with Type 2 Diabetes N Engl J Med
2003;348:383-93.
12. Selvin E, Marinopolus S, Berkenbliit G et al.Meta-analysis
:glicosilated hemoglobin and cardiovascular disease in diabetes
mellitus .Ann Intern Med 2004,141:421-431
13.DECODE. Glucose tolerance and mortality: comparison of WHO and
American Diabetic Association diagnostic criteria Lancet 1999; 354:
617-621)
14.Zavala C y Florenzano F. Macroangiopatía Diabética. En: García de
los Ríos M, Durruty P ed Diabetes Mellitus 2ª Ed 2003; 187-198
15.Malmberg K, Norhammar A, Wedel H et al. Glycometabolic state at
admision: important risk marker of mortality in conventionally treted
patients with diabetes mellitus and myocardialinfarction: Long term
ResultsFromtheDiabetesandInsulin-GlucoseInfusioninAcuteMyocardial
Infarction (DIGAMI) Study: Circulation 1999; 99: 2626-2632
16.Skyler J,Bergenstald R,Bonow RO et al.:Intensive Glycemic Control
and the Prevention of Cardiovascular Events: Implications of the
ACCORD, ADVANCE, and VA Diabetes Trials. A position statement of
the American Diabetes Association and a scientific statement of the
American College of Cardiology Foundation and the American Heart
Association. Diabetes Care 2009; 32:187-192
17.University Group Diabetes Program (1970) A study of the effects of
hypoglycemic agents on vascular complications in patients with adult-
onset diabetes: Sections I and II. Diabetes 19 (Suppl 2): 747–830
18.Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial
infarction and death from cardiovascular causes. N Engl J Med
2007;356:2457-71.)
19.Lago RM, Singh PP, and Nesto RW. Congestive heart failure and
cardiovascular death in patients with prediabetes and type 2
diabetes given thiazolidinediones: a meta-analysis of randomised
clinical trials. Lancet 2007; 370: 1129-1136.
20. Stone NJ, Robinson J, Lichtenstein AH et al.2013 ACC/AHA Guideline
on the Treatment of Blood Cholesterol to Reduce Atherosclerotic
Cardiovascular Risk in Adults: A Report of the American College
of Cardiology/American Heart Association Task Force on Practice
Guidelines. Circulation is available at
http://circ.ahajournals.org21.Standards of Medical Care in Diabetes – Diabetes Care 2015;38
(Suppl. 1):S49–S57
22. Sarafidis PA and Bakris GL. Microalbuminuria and chronic kidney
disease as risk factors for cardiovascular disease Nephrol Dial
Transplant 2006;21:2366-2374.
23. Renal failure in diabetics in UK : deficient provision of care in 1985.
Joint Working Party on Diabetic Renal Failure of the British Diabetic
Association ,the Renal Association, and the Research Unit of the
Royal College of Physicians .Diabetes Med 1988; 5 : 79 – 84
24. Marre M, Jeunemaitre X, Gallois Y, et al. Contribution of genetic
polimorfism in the rennin angiotensin system to development of
renal complications in insulin–dependent diabetes : Genetique de
la Nephropathie Diabetique (GENEDIAB) study group. J Clin Invest
1997;99:1585-95Polimorfimo
25. The BARI 2D Study Group. A Randomized Trial of Therapies for Type
2 Diabetes and Coronary Artery Disease. 2009; 360: 2503 – 2515
26. Farkough ME, Domanski M, Sleeper LA et al. NEJM 2012; 367:
2375-84.
27. Ogawa H, Nakayama M, Morimoto et al.: Low-Dose aqspirin for
primary prevention of atherosclerotic events in patients with type 2
diabetes. A randomized controlled trial. JAMA 2009; 12: 2134-2141
28. Fonarow GC. Srikanthan P. Diabetic cardiomyopathy. Endocrinol
Metab Clin North Am. 2006; 35: 575-599
29. Vinik AI, Ziegler D: Diabetic cardiovasclar autonomic neuropathy.
Circulation 2007; 115:387- 397
30. Maser RE, Mitchel BD Vinik AI, et al.: The association between
cardiovascular autonomic neuropathy and mortality in individuals
with diabetes a meta-analysis. Diabetes Care 2003; 26: 1895-1901
31.Ewing DJ,Martyn CN,Youn RJ et al The value of cardiovascular
autonomic function test: 10 years experience in diabetes . Diabetes
Care 1985; 8: 491-498
[REV. MED. CLIN. CONDES - 2015; 26(2) 175-185]